Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mammography | 146 | 2024 | 2423 | 15.960 |
Why?
|
Breast Neoplasms | 244 | 2024 | 21072 | 10.630 |
Why?
|
Breast | 75 | 2023 | 1950 | 7.660 |
Why?
|
Ultrasonography, Mammary | 25 | 2021 | 243 | 5.620 |
Why?
|
Early Detection of Cancer | 72 | 2024 | 3237 | 4.470 |
Why?
|
Magnetic Resonance Imaging | 102 | 2023 | 36547 | 3.840 |
Why?
|
Mass Screening | 55 | 2022 | 5450 | 3.400 |
Why?
|
Carcinoma, Ductal, Breast | 22 | 2021 | 1086 | 2.750 |
Why?
|
Image Interpretation, Computer-Assisted | 28 | 2021 | 3360 | 2.660 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 20 | 2022 | 921 | 2.620 |
Why?
|
Diffusion Magnetic Resonance Imaging | 23 | 2019 | 2806 | 2.050 |
Why?
|
Breast Diseases | 11 | 2014 | 436 | 2.050 |
Why?
|
Image Enhancement | 24 | 2021 | 2857 | 1.970 |
Why?
|
Biopsy, Needle | 17 | 2022 | 1613 | 1.880 |
Why?
|
Radiographic Image Enhancement | 6 | 2019 | 873 | 1.810 |
Why?
|
Sensitivity and Specificity | 71 | 2021 | 14644 | 1.690 |
Why?
|
Biopsy | 39 | 2020 | 6768 | 1.500 |
Why?
|
Contrast Media | 31 | 2021 | 5330 | 1.430 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 6 | 2019 | 1225 | 1.400 |
Why?
|
Gadolinium DTPA | 16 | 2015 | 822 | 1.330 |
Why?
|
Artificial Intelligence | 11 | 2023 | 2662 | 1.330 |
Why?
|
Carcinoma in Situ | 11 | 2019 | 777 | 1.270 |
Why?
|
Female | 248 | 2024 | 396174 | 1.210 |
Why?
|
Radiology | 19 | 2021 | 2105 | 1.210 |
Why?
|
Fiducial Markers | 2 | 2020 | 134 | 1.210 |
Why?
|
Middle Aged | 169 | 2024 | 223035 | 1.090 |
Why?
|
Benchmarking | 6 | 2018 | 1055 | 1.010 |
Why?
|
Aged | 131 | 2024 | 171170 | 0.990 |
Why?
|
Lymph Nodes | 7 | 2021 | 3457 | 0.980 |
Why?
|
Preoperative Care | 9 | 2021 | 2249 | 0.960 |
Why?
|
Humans | 277 | 2024 | 766019 | 0.940 |
Why?
|
Radiography, Interventional | 3 | 2020 | 1128 | 0.900 |
Why?
|
Retrospective Studies | 72 | 2024 | 81544 | 0.880 |
Why?
|
Reproducibility of Results | 45 | 2021 | 20135 | 0.870 |
Why?
|
Adult | 141 | 2024 | 223110 | 0.860 |
Why?
|
Practice Guidelines as Topic | 15 | 2020 | 7423 | 0.840 |
Why?
|
Palpation | 7 | 2016 | 166 | 0.820 |
Why?
|
Aged, 80 and over | 54 | 2021 | 59497 | 0.760 |
Why?
|
Diagnosis, Differential | 27 | 2021 | 12975 | 0.740 |
Why?
|
Stereotaxic Techniques | 5 | 2010 | 551 | 0.740 |
Why?
|
Axilla | 9 | 2024 | 619 | 0.730 |
Why?
|
Sentinel Lymph Node Biopsy | 4 | 2014 | 733 | 0.670 |
Why?
|
Unnecessary Procedures | 3 | 2017 | 412 | 0.640 |
Why?
|
Registries | 20 | 2019 | 8343 | 0.630 |
Why?
|
Risk Assessment | 27 | 2024 | 24272 | 0.610 |
Why?
|
Medical Oncology | 7 | 2021 | 2339 | 0.600 |
Why?
|
Delayed Diagnosis | 2 | 2021 | 452 | 0.590 |
Why?
|
Ultrasonography, Interventional | 3 | 2018 | 1520 | 0.580 |
Why?
|
Wireless Technology | 1 | 2018 | 99 | 0.580 |
Why?
|
Health Literacy | 2 | 2021 | 465 | 0.580 |
Why?
|
Needles | 3 | 2018 | 460 | 0.570 |
Why?
|
Healthcare Disparities | 4 | 2021 | 3406 | 0.570 |
Why?
|
Predictive Value of Tests | 27 | 2018 | 15403 | 0.560 |
Why?
|
Mastectomy | 6 | 2022 | 1848 | 0.560 |
Why?
|
Utilization Review | 1 | 2018 | 381 | 0.540 |
Why?
|
ROC Curve | 14 | 2024 | 3614 | 0.530 |
Why?
|
False Positive Reactions | 11 | 2019 | 956 | 0.520 |
Why?
|
Neoplasm Invasiveness | 13 | 2020 | 3604 | 0.500 |
Why?
|
Magnetics | 1 | 2018 | 586 | 0.500 |
Why?
|
Algorithms | 10 | 2020 | 14065 | 0.490 |
Why?
|
Neoplasms, Unknown Primary | 2 | 2014 | 102 | 0.480 |
Why?
|
Biopsy, Fine-Needle | 3 | 2018 | 1131 | 0.480 |
Why?
|
Allied Health Personnel | 1 | 2016 | 156 | 0.470 |
Why?
|
Imaging, Three-Dimensional | 8 | 2018 | 4045 | 0.460 |
Why?
|
United States | 45 | 2024 | 72918 | 0.460 |
Why?
|
Mammary Glands, Human | 1 | 2015 | 199 | 0.440 |
Why?
|
Neoadjuvant Therapy | 9 | 2024 | 2897 | 0.420 |
Why?
|
Surgery, Computer-Assisted | 3 | 2009 | 996 | 0.410 |
Why?
|
Population Surveillance | 5 | 2016 | 2594 | 0.410 |
Why?
|
Diagnostic Imaging | 6 | 2021 | 3530 | 0.410 |
Why?
|
Vacuum | 6 | 2010 | 64 | 0.410 |
Why?
|
Area Under Curve | 7 | 2014 | 1638 | 0.400 |
Why?
|
Patient-Centered Care | 2 | 2013 | 1447 | 0.400 |
Why?
|
Triage | 1 | 2019 | 994 | 0.400 |
Why?
|
Breast Cyst | 1 | 2011 | 8 | 0.390 |
Why?
|
Clinical Competence | 4 | 2016 | 4859 | 0.390 |
Why?
|
Hyperplasia | 4 | 2011 | 1142 | 0.380 |
Why?
|
Washington | 9 | 2017 | 315 | 0.370 |
Why?
|
Neoplasm Staging | 20 | 2019 | 11202 | 0.370 |
Why?
|
Neoplasms, Second Primary | 5 | 2020 | 1056 | 0.370 |
Why?
|
Diagnostic Errors | 4 | 2013 | 1276 | 0.370 |
Why?
|
Lymphatic Metastasis | 7 | 2020 | 2890 | 0.370 |
Why?
|
Chi-Square Distribution | 8 | 2012 | 3431 | 0.370 |
Why?
|
Evidence-Based Medicine | 8 | 2016 | 3689 | 0.360 |
Why?
|
Logistic Models | 13 | 2022 | 13272 | 0.360 |
Why?
|
Risk Factors | 34 | 2024 | 74837 | 0.360 |
Why?
|
Precancerous Conditions | 1 | 2017 | 975 | 0.360 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2012 | 194 | 0.350 |
Why?
|
Community Health Services | 2 | 2008 | 657 | 0.350 |
Why?
|
Professional Competence | 1 | 2013 | 429 | 0.340 |
Why?
|
Behavioral Risk Factor Surveillance System | 3 | 2020 | 212 | 0.330 |
Why?
|
Neoplasms, Multiple Primary | 3 | 2010 | 590 | 0.310 |
Why?
|
Educational Measurement | 2 | 2013 | 1259 | 0.300 |
Why?
|
Lymph Node Excision | 2 | 2012 | 1262 | 0.300 |
Why?
|
Ambulatory Care | 1 | 2019 | 2778 | 0.300 |
Why?
|
Observer Variation | 5 | 2016 | 2611 | 0.300 |
Why?
|
Disclosure | 1 | 2013 | 756 | 0.290 |
Why?
|
Carcinoma, Lobular | 5 | 2018 | 471 | 0.290 |
Why?
|
Surgical Instruments | 1 | 2009 | 379 | 0.280 |
Why?
|
Image Processing, Computer-Assisted | 8 | 2022 | 8925 | 0.280 |
Why?
|
Receptors, Progesterone | 5 | 2024 | 1152 | 0.270 |
Why?
|
Insurance, Health | 1 | 2019 | 2520 | 0.270 |
Why?
|
Kinetics | 4 | 2019 | 6273 | 0.260 |
Why?
|
Prospective Studies | 25 | 2024 | 54804 | 0.260 |
Why?
|
Young Adult | 17 | 2021 | 59858 | 0.260 |
Why?
|
Genes, BRCA2 | 3 | 2020 | 591 | 0.260 |
Why?
|
Carcinoma | 1 | 2017 | 2313 | 0.260 |
Why?
|
Referral and Consultation | 1 | 2019 | 3617 | 0.260 |
Why?
|
Program Evaluation | 3 | 2019 | 2501 | 0.260 |
Why?
|
Artifacts | 2 | 2013 | 1896 | 0.240 |
Why?
|
Chemotherapy, Adjuvant | 4 | 2021 | 3546 | 0.240 |
Why?
|
Watchful Waiting | 2 | 2020 | 492 | 0.230 |
Why?
|
Needs Assessment | 3 | 2019 | 1140 | 0.230 |
Why?
|
Receptors, Estrogen | 6 | 2024 | 2242 | 0.230 |
Why?
|
Age Factors | 15 | 2019 | 18382 | 0.230 |
Why?
|
Developing Countries | 5 | 2016 | 2913 | 0.230 |
Why?
|
Uganda | 4 | 2017 | 1353 | 0.220 |
Why?
|
Radiology Department, Hospital | 1 | 2008 | 409 | 0.220 |
Why?
|
Guideline Adherence | 3 | 2019 | 2234 | 0.220 |
Why?
|
Receptor, erbB-3 | 1 | 2024 | 141 | 0.210 |
Why?
|
Cohort Studies | 16 | 2022 | 41677 | 0.210 |
Why?
|
Quality Assurance, Health Care | 2 | 2013 | 2171 | 0.210 |
Why?
|
Physical Examination | 6 | 2019 | 1263 | 0.210 |
Why?
|
Clinical Trials as Topic | 9 | 2021 | 8037 | 0.200 |
Why?
|
Breast Self-Examination | 5 | 2017 | 33 | 0.200 |
Why?
|
Incidence | 9 | 2024 | 21509 | 0.200 |
Why?
|
Architectural Accessibility | 1 | 2021 | 24 | 0.200 |
Why?
|
Radiology, Interventional | 1 | 2006 | 484 | 0.190 |
Why?
|
Societies, Medical | 4 | 2018 | 3955 | 0.190 |
Why?
|
Blood Component Removal | 2 | 2002 | 124 | 0.190 |
Why?
|
Tobacco Use Cessation | 2 | 2020 | 100 | 0.190 |
Why?
|
Collagen | 1 | 2009 | 2618 | 0.190 |
Why?
|
Health Knowledge, Attitudes, Practice | 4 | 2018 | 4053 | 0.190 |
Why?
|
Receptor, erbB-2 | 5 | 2024 | 2593 | 0.190 |
Why?
|
Feasibility Studies | 4 | 2024 | 5301 | 0.180 |
Why?
|
Age Distribution | 4 | 2017 | 2865 | 0.180 |
Why?
|
Prognosis | 11 | 2022 | 29905 | 0.180 |
Why?
|
Confidence Intervals | 3 | 2019 | 2915 | 0.180 |
Why?
|
Patient Compliance | 3 | 2024 | 2694 | 0.180 |
Why?
|
Patient Acceptance of Health Care | 3 | 2020 | 3229 | 0.170 |
Why?
|
Appointments and Schedules | 1 | 2024 | 441 | 0.170 |
Why?
|
Positron-Emission Tomography | 6 | 2024 | 6545 | 0.170 |
Why?
|
Time | 1 | 2021 | 549 | 0.160 |
Why?
|
Terminology as Topic | 2 | 2010 | 1536 | 0.160 |
Why?
|
Follow-Up Studies | 10 | 2021 | 39233 | 0.160 |
Why?
|
Health Services Accessibility | 4 | 2019 | 5510 | 0.160 |
Why?
|
Neoplasm, Residual | 5 | 2018 | 1009 | 0.160 |
Why?
|
False Negative Reactions | 2 | 2018 | 570 | 0.160 |
Why?
|
Vaccination | 2 | 2021 | 3431 | 0.160 |
Why?
|
Search Engine | 1 | 2019 | 142 | 0.150 |
Why?
|
Breast Neoplasms, Male | 1 | 2020 | 213 | 0.150 |
Why?
|
Prevalence | 6 | 2016 | 15820 | 0.150 |
Why?
|
Comprehension | 2 | 2021 | 636 | 0.140 |
Why?
|
Radiology Information Systems | 1 | 2002 | 535 | 0.140 |
Why?
|
Magnetic Resonance Spectroscopy | 3 | 2022 | 3679 | 0.140 |
Why?
|
Nasopharynx | 1 | 2020 | 419 | 0.140 |
Why?
|
Insurance Coverage | 2 | 2019 | 1945 | 0.140 |
Why?
|
SEER Program | 4 | 2019 | 1443 | 0.140 |
Why?
|
Antigens, CD34 | 2 | 2002 | 656 | 0.140 |
Why?
|
Blood Specimen Collection | 1 | 1998 | 238 | 0.140 |
Why?
|
Time Factors | 11 | 2024 | 40100 | 0.140 |
Why?
|
Reference Values | 4 | 2019 | 4909 | 0.140 |
Why?
|
Truth Disclosure | 2 | 2012 | 433 | 0.130 |
Why?
|
Feedback | 1 | 2020 | 796 | 0.130 |
Why?
|
Health Facilities | 3 | 2018 | 578 | 0.130 |
Why?
|
Anisotropy | 2 | 2010 | 1285 | 0.130 |
Why?
|
Diagnosis, Computer-Assisted | 3 | 2013 | 698 | 0.130 |
Why?
|
Physician's Role | 2 | 2013 | 925 | 0.130 |
Why?
|
Saliva | 1 | 2020 | 852 | 0.130 |
Why?
|
Elasticity Imaging Techniques | 1 | 2021 | 397 | 0.130 |
Why?
|
Reading | 1 | 2019 | 540 | 0.130 |
Why?
|
Lidocaine | 2 | 1999 | 545 | 0.130 |
Why?
|
Lung Neoplasms | 4 | 2021 | 13483 | 0.130 |
Why?
|
Chorda Tympani Nerve | 1 | 1995 | 11 | 0.130 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2017 | 9378 | 0.130 |
Why?
|
Taste Buds | 1 | 1995 | 23 | 0.120 |
Why?
|
Ultrasonography | 3 | 2021 | 5988 | 0.120 |
Why?
|
Eligibility Determination | 1 | 2019 | 422 | 0.120 |
Why?
|
Radiopharmaceuticals | 4 | 2017 | 2701 | 0.120 |
Why?
|
Hydrogels | 1 | 2020 | 729 | 0.120 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2017 | 2028 | 0.120 |
Why?
|
Equipment Design | 2 | 2018 | 3489 | 0.120 |
Why?
|
Choline | 1 | 2016 | 511 | 0.120 |
Why?
|
Genes, BRCA1 | 2 | 2009 | 753 | 0.120 |
Why?
|
Adolescent | 13 | 2019 | 88808 | 0.110 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 1995 | 191 | 0.110 |
Why?
|
Radiography | 2 | 2021 | 6943 | 0.110 |
Why?
|
Menstrual Cycle | 2 | 2013 | 539 | 0.110 |
Why?
|
Multivariate Analysis | 6 | 2019 | 12061 | 0.110 |
Why?
|
Radiation Oncology | 1 | 2020 | 568 | 0.110 |
Why?
|
Taste | 1 | 1995 | 190 | 0.110 |
Why?
|
Patient Care Planning | 2 | 2016 | 903 | 0.110 |
Why?
|
Trisomy | 1 | 1995 | 260 | 0.110 |
Why?
|
Cell Separation | 1 | 1998 | 1718 | 0.100 |
Why?
|
Pandemics | 3 | 2021 | 8724 | 0.100 |
Why?
|
Cross-Over Studies | 1 | 2019 | 2108 | 0.100 |
Why?
|
Evaluation Studies as Topic | 1 | 2015 | 1607 | 0.100 |
Why?
|
Health Services Misuse | 1 | 2014 | 245 | 0.100 |
Why?
|
Patient Access to Records | 1 | 2013 | 120 | 0.100 |
Why?
|
Risk Reduction Behavior | 1 | 2019 | 1120 | 0.100 |
Why?
|
RNA, Viral | 1 | 2020 | 2868 | 0.100 |
Why?
|
Statistics, Nonparametric | 3 | 2012 | 2844 | 0.100 |
Why?
|
Physicians, Primary Care | 1 | 2019 | 622 | 0.100 |
Why?
|
Patient Education as Topic | 2 | 2021 | 2332 | 0.100 |
Why?
|
Equipment Safety | 1 | 2013 | 250 | 0.100 |
Why?
|
Photomicrography | 1 | 2011 | 71 | 0.100 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2015 | 11859 | 0.100 |
Why?
|
Data Mining | 1 | 2016 | 560 | 0.090 |
Why?
|
Lithotripsy, Laser | 1 | 1991 | 43 | 0.090 |
Why?
|
Mandatory Reporting | 1 | 2012 | 123 | 0.090 |
Why?
|
Phantoms, Imaging | 3 | 2011 | 2474 | 0.090 |
Why?
|
Internet | 2 | 2021 | 3107 | 0.090 |
Why?
|
Multicenter Studies as Topic | 3 | 2011 | 1729 | 0.090 |
Why?
|
Software | 3 | 2013 | 4463 | 0.090 |
Why?
|
Women's Health | 2 | 2013 | 2080 | 0.090 |
Why?
|
Patient Participation | 1 | 2020 | 1446 | 0.090 |
Why?
|
Lithotripsy | 1 | 1991 | 137 | 0.090 |
Why?
|
Metabolic Clearance Rate | 1 | 2011 | 361 | 0.090 |
Why?
|
Radio Waves | 1 | 2012 | 246 | 0.090 |
Why?
|
Secondary Prevention | 1 | 2016 | 1469 | 0.090 |
Why?
|
Cross-Sectional Studies | 7 | 2020 | 26280 | 0.090 |
Why?
|
Spouses | 1 | 2013 | 286 | 0.090 |
Why?
|
Curriculum | 3 | 2020 | 3784 | 0.090 |
Why?
|
Hematopoietic Stem Cells | 2 | 2002 | 3405 | 0.080 |
Why?
|
Cholelithiasis | 1 | 1991 | 408 | 0.080 |
Why?
|
Gadolinium | 1 | 2015 | 966 | 0.080 |
Why?
|
Vulnerable Populations | 1 | 2015 | 717 | 0.080 |
Why?
|
Carcinoma, Ductal | 2 | 2011 | 97 | 0.080 |
Why?
|
Tumor Burden | 4 | 2018 | 1889 | 0.080 |
Why?
|
Neoplasm Metastasis | 2 | 2016 | 4886 | 0.080 |
Why?
|
Linear Models | 1 | 2019 | 5872 | 0.080 |
Why?
|
Odds Ratio | 6 | 2022 | 9655 | 0.080 |
Why?
|
Oxygen Radioisotopes | 1 | 2008 | 60 | 0.080 |
Why?
|
Phytoestrogens | 1 | 2008 | 59 | 0.080 |
Why?
|
Academic Medical Centers | 1 | 2019 | 2782 | 0.080 |
Why?
|
Problem Solving | 1 | 2011 | 442 | 0.080 |
Why?
|
Specimen Handling | 2 | 2020 | 704 | 0.080 |
Why?
|
Socioeconomic Factors | 5 | 2024 | 7840 | 0.080 |
Why?
|
Loss of Heterozygosity | 1 | 2010 | 663 | 0.080 |
Why?
|
Interpersonal Relations | 1 | 2015 | 1432 | 0.070 |
Why?
|
Computer Simulation | 2 | 2019 | 6254 | 0.070 |
Why?
|
Nerve Block | 1 | 1995 | 717 | 0.070 |
Why?
|
Smoking Cessation | 1 | 2020 | 2082 | 0.070 |
Why?
|
Attitude to Health | 1 | 2017 | 2020 | 0.070 |
Why?
|
Isoflavones | 1 | 2008 | 139 | 0.070 |
Why?
|
Absorptiometry, Photon | 1 | 2013 | 1707 | 0.070 |
Why?
|
Fetus | 1 | 1995 | 1878 | 0.070 |
Why?
|
Cost-Benefit Analysis | 3 | 2015 | 5528 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 3 | 2019 | 20699 | 0.070 |
Why?
|
Analysis of Variance | 2 | 2013 | 6208 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 4 | 2020 | 18075 | 0.070 |
Why?
|
Stainless Steel | 2 | 2004 | 79 | 0.070 |
Why?
|
Self Report | 1 | 2018 | 3769 | 0.070 |
Why?
|
Health Resources | 2 | 2003 | 951 | 0.070 |
Why?
|
Ultrasonography, Prenatal | 1 | 1995 | 1772 | 0.070 |
Why?
|
Likelihood Functions | 1 | 2009 | 993 | 0.070 |
Why?
|
Carcinoma, Medullary | 1 | 2006 | 115 | 0.060 |
Why?
|
Case-Control Studies | 5 | 2018 | 22230 | 0.060 |
Why?
|
Incidental Findings | 1 | 2011 | 698 | 0.060 |
Why?
|
Databases, Factual | 2 | 2018 | 8062 | 0.060 |
Why?
|
Probability | 1 | 2011 | 2475 | 0.060 |
Why?
|
Decision Making | 1 | 2019 | 3954 | 0.060 |
Why?
|
Informed Consent | 1 | 2012 | 1010 | 0.060 |
Why?
|
Pilot Projects | 2 | 2010 | 8723 | 0.060 |
Why?
|
Risk | 3 | 2020 | 9598 | 0.060 |
Why?
|
Models, Statistical | 3 | 2011 | 5088 | 0.060 |
Why?
|
Radiation Injuries | 1 | 2012 | 1181 | 0.060 |
Why?
|
Immunohistochemistry | 2 | 2024 | 11035 | 0.060 |
Why?
|
Laser Therapy | 1 | 1991 | 1108 | 0.060 |
Why?
|
Computer-Assisted Instruction | 1 | 2007 | 368 | 0.060 |
Why?
|
National Cancer Institute (U.S.) | 2 | 2020 | 299 | 0.060 |
Why?
|
Chronic Disease | 1 | 2018 | 9351 | 0.050 |
Why?
|
Health Promotion | 1 | 2015 | 2207 | 0.050 |
Why?
|
Decision Support Techniques | 1 | 2013 | 2005 | 0.050 |
Why?
|
Medical Errors | 1 | 2012 | 1260 | 0.050 |
Why?
|
Health Care Surveys | 1 | 2010 | 2425 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2021 | 10380 | 0.050 |
Why?
|
Calcinosis | 2 | 2010 | 1475 | 0.050 |
Why?
|
Health Planning Guidelines | 1 | 2003 | 151 | 0.050 |
Why?
|
Testosterone | 1 | 2013 | 2495 | 0.050 |
Why?
|
Physicians | 1 | 2020 | 4590 | 0.050 |
Why?
|
Survivors | 1 | 2013 | 2375 | 0.050 |
Why?
|
Education, Medical, Continuing | 1 | 2007 | 829 | 0.050 |
Why?
|
Turkeys | 1 | 2001 | 44 | 0.050 |
Why?
|
Regression Analysis | 3 | 2019 | 6324 | 0.050 |
Why?
|
Patient Selection | 2 | 2013 | 4249 | 0.050 |
Why?
|
Mental Disorders | 1 | 2022 | 6870 | 0.050 |
Why?
|
Early Diagnosis | 1 | 2006 | 1186 | 0.050 |
Why?
|
Physician-Patient Relations | 2 | 2012 | 3269 | 0.050 |
Why?
|
Ukraine | 1 | 2001 | 151 | 0.040 |
Why?
|
Titanium | 1 | 2003 | 490 | 0.040 |
Why?
|
Community Health Centers | 1 | 2024 | 469 | 0.040 |
Why?
|
Internship and Residency | 1 | 2020 | 5946 | 0.040 |
Why?
|
Treatment Outcome | 6 | 2021 | 65203 | 0.040 |
Why?
|
Quality of Life | 1 | 2021 | 13464 | 0.040 |
Why?
|
Teaching | 1 | 2007 | 1170 | 0.040 |
Why?
|
Taiwan | 1 | 2021 | 521 | 0.040 |
Why?
|
Spectrum Analysis | 1 | 2021 | 443 | 0.040 |
Why?
|
Adipose Tissue | 1 | 2011 | 3314 | 0.040 |
Why?
|
Mastectomy, Segmental | 2 | 2019 | 965 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2016 | 4863 | 0.040 |
Why?
|
Genetic Testing | 2 | 2009 | 3592 | 0.040 |
Why?
|
Disease-Free Survival | 3 | 2015 | 6840 | 0.040 |
Why?
|
Neoplasms | 2 | 2020 | 22336 | 0.040 |
Why?
|
Puerto Rico | 1 | 2020 | 380 | 0.040 |
Why?
|
Neovascularization, Pathologic | 1 | 2008 | 2627 | 0.040 |
Why?
|
Sweden | 1 | 2021 | 1381 | 0.040 |
Why?
|
Medical Records | 1 | 2003 | 1408 | 0.040 |
Why?
|
Proprioception | 1 | 1999 | 134 | 0.040 |
Why?
|
Longitudinal Studies | 3 | 2019 | 14747 | 0.040 |
Why?
|
Premenopause | 1 | 2021 | 1039 | 0.030 |
Why?
|
Accreditation | 1 | 2020 | 476 | 0.030 |
Why?
|
Obesity | 1 | 2019 | 13082 | 0.030 |
Why?
|
Exercise | 1 | 2013 | 5939 | 0.030 |
Why?
|
Universities | 1 | 2021 | 1004 | 0.030 |
Why?
|
Breast Implants | 1 | 2000 | 411 | 0.030 |
Why?
|
Taste Threshold | 1 | 1995 | 7 | 0.030 |
Why?
|
Glossopharyngeal Nerve | 1 | 1995 | 18 | 0.030 |
Why?
|
Health Communication | 1 | 2018 | 216 | 0.030 |
Why?
|
Mutation | 1 | 2020 | 30210 | 0.030 |
Why?
|
Male | 10 | 2020 | 363880 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 2020 | 789 | 0.030 |
Why?
|
Ki-67 Antigen | 1 | 2017 | 628 | 0.030 |
Why?
|
Leukocyte Count | 1 | 1998 | 1605 | 0.030 |
Why?
|
Cell Count | 1 | 1998 | 1825 | 0.030 |
Why?
|
Sentinel Surveillance | 1 | 2016 | 292 | 0.030 |
Why?
|
North Carolina | 1 | 2015 | 329 | 0.030 |
Why?
|
Pregnancy, High-Risk | 1 | 1995 | 121 | 0.030 |
Why?
|
Cost Control | 1 | 2016 | 626 | 0.030 |
Why?
|
Afferent Pathways | 1 | 1995 | 303 | 0.030 |
Why?
|
Heterocyclic Compounds | 1 | 2015 | 245 | 0.030 |
Why?
|
Culture | 1 | 2017 | 622 | 0.030 |
Why?
|
Rupture | 1 | 1995 | 444 | 0.030 |
Why?
|
Interdisciplinary Communication | 1 | 2019 | 931 | 0.030 |
Why?
|
Awareness | 1 | 2017 | 653 | 0.030 |
Why?
|
Catheter Ablation | 1 | 2006 | 2787 | 0.030 |
Why?
|
Karyotyping | 1 | 1995 | 1175 | 0.030 |
Why?
|
Intention | 1 | 2015 | 346 | 0.030 |
Why?
|
Fear | 1 | 2021 | 1496 | 0.030 |
Why?
|
Postmenopause | 1 | 2021 | 2517 | 0.020 |
Why?
|
Body Mass Index | 2 | 2021 | 13042 | 0.020 |
Why?
|
Calibration | 1 | 2015 | 813 | 0.020 |
Why?
|
Language | 1 | 2021 | 1550 | 0.020 |
Why?
|
Pedigree | 1 | 2020 | 4535 | 0.020 |
Why?
|
Health Care Costs | 2 | 2016 | 3240 | 0.020 |
Why?
|
X-Ray Film | 1 | 2011 | 31 | 0.020 |
Why?
|
Tongue | 1 | 1995 | 406 | 0.020 |
Why?
|
Shoulder Joint | 1 | 1999 | 740 | 0.020 |
Why?
|
Maternal Age | 1 | 1995 | 804 | 0.020 |
Why?
|
Viral Load | 1 | 2020 | 3386 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2009 | 6361 | 0.020 |
Why?
|
Organometallic Compounds | 1 | 2015 | 645 | 0.020 |
Why?
|
Receptors, Steroid | 1 | 2011 | 156 | 0.020 |
Why?
|
Neural Inhibition | 1 | 1995 | 589 | 0.020 |
Why?
|
Cadaver | 1 | 1995 | 1362 | 0.020 |
Why?
|
Pattern Recognition, Automated | 1 | 2016 | 979 | 0.020 |
Why?
|
Quality Control | 1 | 2013 | 835 | 0.020 |
Why?
|
Molecular Imaging | 1 | 2016 | 822 | 0.020 |
Why?
|
Diffusion | 1 | 2011 | 808 | 0.020 |
Why?
|
Anthracyclines | 1 | 2011 | 285 | 0.020 |
Why?
|
Hydroxyestrones | 1 | 2008 | 17 | 0.020 |
Why?
|
Health Surveys | 1 | 2019 | 4054 | 0.020 |
Why?
|
Soy Foods | 1 | 2008 | 44 | 0.020 |
Why?
|
Taxoids | 1 | 2011 | 665 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2020 | 2419 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2024 | 8613 | 0.020 |
Why?
|
Quality-Adjusted Life Years | 1 | 2015 | 1737 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8524 | 0.020 |
Why?
|
Family Health | 1 | 2013 | 1253 | 0.020 |
Why?
|
Minority Groups | 1 | 2015 | 1208 | 0.020 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2008 | 355 | 0.020 |
Why?
|
Educational Status | 1 | 2015 | 2507 | 0.020 |
Why?
|
Decision Support Systems, Clinical | 1 | 2016 | 1177 | 0.020 |
Why?
|
Antineoplastic Agents | 2 | 2008 | 13635 | 0.020 |
Why?
|
World Health Organization | 2 | 2003 | 1326 | 0.020 |
Why?
|
Social Class | 1 | 2015 | 2006 | 0.020 |
Why?
|
Anxiety | 1 | 2021 | 4671 | 0.020 |
Why?
|
Focus Groups | 1 | 2013 | 1459 | 0.020 |
Why?
|
Estrogens | 1 | 2013 | 1528 | 0.020 |
Why?
|
Comparative Effectiveness Research | 1 | 2011 | 713 | 0.020 |
Why?
|
Medicaid | 1 | 2019 | 2835 | 0.020 |
Why?
|
Massachusetts | 1 | 2018 | 8882 | 0.020 |
Why?
|
Exercise Test | 1 | 2013 | 2185 | 0.020 |
Why?
|
Phenotype | 2 | 2017 | 16714 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2003 | 5365 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 2008 | 1378 | 0.010 |
Why?
|
Malpractice | 1 | 2009 | 561 | 0.010 |
Why?
|
Rural Population | 1 | 2015 | 2317 | 0.010 |
Why?
|
Menopause | 1 | 2011 | 1658 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2022 | 16040 | 0.010 |
Why?
|
Congresses as Topic | 1 | 2008 | 811 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2008 | 1777 | 0.010 |
Why?
|
Health Expenditures | 1 | 2015 | 2389 | 0.010 |
Why?
|
Child | 1 | 2010 | 80567 | 0.010 |
Why?
|
Patient Rights | 1 | 2003 | 126 | 0.010 |
Why?
|
Water | 1 | 2008 | 1416 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7870 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6506 | 0.010 |
Why?
|
Signal Transduction | 1 | 2024 | 23600 | 0.010 |
Why?
|
Blood Cell Count | 1 | 2002 | 404 | 0.010 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2002 | 227 | 0.010 |
Why?
|
Data Collection | 1 | 2009 | 3318 | 0.010 |
Why?
|
Pathology | 1 | 2003 | 270 | 0.010 |
Why?
|
Health Care Rationing | 1 | 2003 | 435 | 0.010 |
Why?
|
Recurrence | 1 | 2012 | 8494 | 0.010 |
Why?
|
Medical History Taking | 1 | 2003 | 779 | 0.010 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2002 | 633 | 0.010 |
Why?
|
Follicular Phase | 1 | 1998 | 143 | 0.010 |
Why?
|
Luteal Phase | 1 | 1998 | 138 | 0.010 |
Why?
|
Mammaplasty | 1 | 2008 | 1264 | 0.010 |
Why?
|
Bayes Theorem | 1 | 2006 | 2352 | 0.010 |
Why?
|
Injections, Intra-Articular | 1 | 1999 | 279 | 0.010 |
Why?
|
Medicare | 1 | 2015 | 6820 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2011 | 12529 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2004 | 1794 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2011 | 9525 | 0.010 |
Why?
|
Communication | 1 | 2009 | 3908 | 0.010 |
Why?
|
Pregnancy | 1 | 1995 | 30228 | 0.010 |
Why?
|
Range of Motion, Articular | 1 | 1999 | 1593 | 0.010 |
Why?
|
Public Health | 1 | 2003 | 2681 | 0.010 |
Why?
|
Animals | 1 | 2001 | 168801 | 0.010 |
Why?
|
Brain | 1 | 2016 | 27175 | 0.000 |
Why?
|
Survival Rate | 1 | 2003 | 12822 | 0.000 |
Why?
|